Women Involved in Heritable Genome Editing and the Need to Recognize Their Irreplaceable Participation
International Journal of Feminist Approaches to Bioethics · 01.10.2026 · 19 (2) · 284-299
DOI: 10.3138/ijfab-2024-0010 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Feminist Approaches to Bioethics, erschienen am 01.10.2026. Verfasst von Elisa Calleja-Sordo. Die Arbeit nennt 51 Literaturangaben.
Abstract (Originalsprache)
Researchers and scientists involved in heritable human genome editing have a duty to the women involved in the editing process. These women are the ones who would gestate genetically altered embryos, but their participation is often rendered invisible by being portrayed as part of an assisted reproductive procedure rather than as participants in a research protocol. Human genome editing is a promising technology that may eliminate monogenetic diseases from embryos, thus procuring better quality of life for the resulting children. Women’s participation in this process has not, however, been as widely recognized as it should be, given that these women must assume the adverse effects of pregnancy, the assisted reproductive procedures, and the unknown consequences from the editing process.
Zitieren
APA
Calleja-Sordo, E. (2026). Women Involved in Heritable Genome Editing and the Need to Recognize Their Irreplaceable Participation. International Journal of Feminist Approaches to Bioethics, 19(2), 284-299. https://doi.org/10.3138/ijfab-2024-0010
Vancouver
Calleja-Sordo E. Women Involved in Heritable Genome Editing and the Need to Recognize Their Irreplaceable Participation. International Journal of Feminist Approaches to Bioethics. 2026;19(2):284-299. doi:10.3138/ijfab-2024-0010
BibTeX
@article{CallejaSordo2026,
author = {Calleja-Sordo, Elisa},
title = {Women Involved in Heritable Genome Editing and the Need to Recognize Their Irreplaceable Participation},
journal = {International Journal of Feminist Approaches to Bioethics},
year = {2026},
volume = {19},
number = {2},
pages = {284--299},
doi = {10.3138/ijfab-2024-0010}
}
EUVIMED